A Study to Assess the Pharmacologic Equivalence of Two Orlistat Dosage Forms.
Phase of Trial: Phase I
Latest Information Update: 11 Aug 2012
At a glance
- Drugs Orlistat (Primary)
- Indications Obesity; Overweight
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 11 Aug 2012 New source identified and integrated (European Clinical Trials Database: EudraCT2008-006986-10).
- 20 Mar 2012 New trial record